Victory Capital Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$93.5K Sell
11,486
-50,854
-82% -$414K ﹤0.01% 2332
2025
Q1
$489K Buy
62,340
+16,622
+36% +$130K ﹤0.01% 2038
2024
Q4
$681K Sell
45,718
-2,764
-6% -$41.2K ﹤0.01% 1947
2024
Q3
$741K Sell
48,482
-1,220
-2% -$18.7K ﹤0.01% 1894
2024
Q2
$757K Sell
49,702
-25,624
-34% -$390K ﹤0.01% 1826
2024
Q1
$1.42M Sell
75,326
-29,087
-28% -$549K ﹤0.01% 1573
2023
Q4
$1.99M Buy
104,413
+36,312
+53% +$694K ﹤0.01% 1429
2023
Q3
$1.22M Sell
68,101
-6,062
-8% -$109K ﹤0.01% 1559
2023
Q2
$1.51M Sell
74,163
-19,903
-21% -$404K ﹤0.01% 1492
2023
Q1
$1.72M Buy
94,066
+28,403
+43% +$518K ﹤0.01% 1453
2022
Q4
$1.36M Buy
65,663
+48,003
+272% +$993K ﹤0.01% 1581
2022
Q3
$462K Buy
17,660
+1,898
+12% +$49.7K ﹤0.01% 2082
2022
Q2
$399K Sell
15,762
-1,469
-9% -$37.2K ﹤0.01% 2149
2022
Q1
$417K Buy
17,231
+10,384
+152% +$251K ﹤0.01% 2191
2021
Q4
$277K Sell
6,847
-436
-6% -$17.6K ﹤0.01% 2404
2021
Q3
$254K Sell
7,283
-63,577
-90% -$2.22M ﹤0.01% 2438
2021
Q2
$1.95M Sell
70,860
-1,459,488
-95% -$40.1M ﹤0.01% 1645
2021
Q1
$43M Buy
1,530,348
+397,786
+35% +$11.2M 0.04% 611
2020
Q4
$29.4M Sell
1,132,562
-55,997
-5% -$1.45M 0.03% 722
2020
Q3
$20.4M Buy
1,188,559
+295,955
+33% +$5.07M 0.03% 791
2020
Q2
$22.1M Buy
892,604
+882,912
+9,110% +$21.8M 0.03% 732
2020
Q1
$134K Buy
+9,692
New +$134K ﹤0.01% 2445
2019
Q4
Sell
-4,491
Closed -$41K 3131
2019
Q3
$41K Buy
+4,491
New +$41K ﹤0.01% 2769